首页> 外文OA文献 >Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays

【2h】

Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays

机译：大麻素1受体（CB1R）激动剂疗效的分层：通过使用转基因小鼠的CB1R密度的操纵揭示了体内和体外测定之间的一致性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
T. W. Grim; A. J. Morales; M. M. Gonek; J. L. Wiley; B. F. Thomas; G. W. Endres; L. J. Sim-Selley; D. E. Selley; S. S. Negus; A. H. Lichtman;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays [J] . Grim T. W., Morales A. J., Gonek M. M., The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2016,第2期

机译：大麻素1受体（CB1R）激动剂的分层：通过使用转基因小鼠CB1R密度的操纵揭示体内和体外测定之间的一致性。
2. Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays [J] . Grim T. W., Morales A. J., Gonek M. M., The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2016,第2期

机译：大麻素1受体（CB1R）激动剂疗效的分层：通过使用转基因小鼠的CB1R密度的操纵揭示了体内和体外测定之间的一致性
3. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity [J] . BrentsL.K., Gallus-ZawadaA., Radominska-PandyaA., Biochemical Pharmacology . 2012,第7期

机译：K2合成大麻素JWH-073的单羟基化代谢物保留了高大麻素1受体（CB1R）亲和力的中间水平，并表现出部分激动剂活性的中性拮抗剂
4. Study of in Vitro Metabolism of LY-320135, a Novel Inverse Agonist for Cannabinoid Receptor (CB1) by HPLC-LTQ Mass Spectrometry [C] . Qiang Zhang, Peng Ma, Guangdi Wang ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：HPLC-LTQ质谱法测定大麻素受体（CB1）的新型逆激动剂的体外代谢研究
5. CB1R cannabinoid receptors allosterically modulate delta opioid receptor activity during neuropathic pain. [D] . Bushlin, Ittai. 2012

机译：CB1R大麻素受体在神经性疼痛过程中变构地调节δ阿片受体的活性。
6. Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays [O] . T. W. Grim, A. J. Morales, M. M. Gonek, -1

机译：大麻素1受体（CB1R）激动剂功效的分层：通过使用转基因小鼠对CB1R密度的操纵揭示了体内和体外试验之间的一致性
7. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity [O] . Lisa K. Brents, Anna Gallus-Zawada, Anna Radominska-Pandya, 2012

机译：K2合成大麻素JWH-073的单羟基化代谢物保留高大麻素1受体（CB1R）亲和力并将中性拮抗剂表现为部分激动剂活性

Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays

著录项

引文网络

相似文献

相关主题

期刊订阅